On the mechanism and dynamics of uptake and permeation of polyether-copolyester dendrimers across an in vitro blood-brain barrier model

Journal of Pharmaceutical Sciences

Volumn 98, Issue 10, 2009, Pages 3748-3760

  Dhanikula, Renu Singh ^a   Hammady, Taha ^a   Hildgen, Patrice ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Blood brain barrier; Dendrimers; In vitro models; Nanotechnology; Permeability

Indexed keywords

4 DIMETHYLAMINOAZOBENZENE; ATENOLOL; CHLORPROMAZINE; CLATHRIN; CYTOCHALASIN B; DENDRIMER; ETHYLENEDIAMINE; POLYAMIDOAMINE; POLYESTER; POLYETHER; POLYETHER COPOLYESTER; RHODAMINE B; THEOPHYLLINE; UNCLASSIFIED DRUG; VERAPAMIL;

ANIMAL CELL; ARTICLE; BLOOD BRAIN BARRIER; CONTROLLED STUDY; CYTOTOXICITY; DRUG PENETRATION; DRUG UPTAKE; ELECTRIC RESISTANCE; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; MOUSE; NONHUMAN;

EID: 67649230473     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.21669     Document Type: Article

References (56)

1. Pardridge WM. 2002. Drug and gene targeting to the brain with molecular Trojan horses. Nat Rev Drug Discov 1:131-139.
2. Bar T. 1980. The vascular system of the cerebral cortex. Adv Anat Embryol Cell Biol 59:1-62.
3. Brightman MW. 1977. Morphology of blood-brain interfaces. Exp Eye Res Suppl 25:1-25.
4. Tsuji A, Tamai I. 1999. Carrier-mediated or specialized transport of drugs across the blood-brain barrier. Adv Drug Deliv Rev 36:277-290. (Pubitemid 29121976)
5. Pardridge WM. 2002. Drug and gene delivery to the brain: The vascular route. Neuron 36:555-558. (Pubitemid 35346750)
6. Alyautidin RN, Petrov VE, Langer K, Berthold A, Kharkievich DA, Kreuter J. 1997. Delivery of loperamide across the blood-brain barrier with polysorbate 80-coated nanoparticles. Pharm Res 14:325-328. (Pubitemid 27160944)
7. Fishman RA, Christy NP. 1965. Fate of adrenal cortical steroids following intrathecal injections. Neurology 15:1-6.
8. Kunwar S. 2003. Convection enhance delivery of IL13-PE38QQR for treatment of recurrent malignant glioma: Presentation of interim findings from ongoing phase 1 studies. Acta Neurochir Suppl 88:105-111.
9. Schwarze SR, Ho A, Vocero-Akbani A, Dowdy SF. 1999. In vivo protein transduction: Delivery of a biologically active protein into the mouse Science. 285:1569-1572.
10. Shoichet MS, Winn SR. 2000. Cell delivery to the central nervous system. Adv Drug Deliv Rev 42:81-102. (Pubitemid 30609636)
11. Siegel T, Rubinstein R, Bokstein F, Schwartz A, Lossos A, Shalom E, Chisin R, Gomori JM. 2000. In vivo assessment of the window of barrier opening after osmotic disruption in humans. J Neurosurg 92:599-605.
12. Westphal M, Ram Z, Riddle V, Hilt D, Bortey E. 2006. Gliadel wafer in initial surgery for malignant glioma: Long-term follow-up of a multicenter controlled trial. Acta Neurochir (Wien) 148:269-275. (Pubitemid 43341024)
13. Zhang Y, Zhu C, Pardridge WM. 2002. Antisense gene therapy of brain cancer with an artificial virus gene delivery system. Mol Ther 6:67-72. (Pubitemid 36124272)
14. Cerletti A, Drewe J, Fricker G, Eberle AN, Huwyler J. 2000. Endocytosis and transcytosis of an immunoliposome- based brain drug delivery system. J Drug Target 8:435-446. (Pubitemid 32366711)
15. Huwyler J, Cerletti A, Fricker G, Eberle AN, Drewe J. 2002. Bypassing of P-glycoprotein using immunoliposomes. J Drug Target 10:73-79.
16. Shi N, Zhang Y, Zhu C, Boado RJ, Pardridge WM. 2001. Brain-specific expression of an exogenous gene after i.v. administration. Proc Natl Acad Sci USA 98:12754-12759. (Pubitemid 33026054)
17. Gulyaev A, Gelperina SE, Skidan IN, Antropov AS, Kivman GY, Kreuter J. 1999. Significant transport of doxorubicin into the brain with polysorbate 80 coated nanoparticles. Pharm Res 16:1564-1569. (Pubitemid 29510553)
18. Calvo P, Gouritin B, Chacun H, Desmaele JDDA, Noel JP, Georgin D, Fattal E, Andreux JP, Couvreur P. 2001. Long-circulating PEGylated polycyanoacrylate nanoparticles as new drug carrier for brain delivery. Pharm Res 18:1157-1166. (Pubitemid 32900402)
19. Kreuter J. 2001. Nanoparticulate systems for brain delivery of drugs. Adv Drug Del Rev 47:65-81. (Pubitemid 32209233)
20. Lockman PR, Mumper RJ, Kahn M, Allen DD. 2002. Nanoparticle technology for drug delivery across the blood-brain barrier. Drug Dev Ind Pharm 28:1-12.
21. Klajnert B, Bryszewska M. 2001. Dendrimers: Properties and applications. Acta Biochim Pol 48:199-208.
22. Aulenta F, Hayes W, Rannard S. 2003. Dendrimers: A new class of nanoscopic containers and delivery devices. Eur Poly J 39:1741-1771.
23. Cloninger M. 2002. Biological applications of dendrimers. Curr Opin Chem Bio 6:742-748.
24. Esfand R, Tomalia DA. 2001. Poly(amidoamine) (PAMAM) dendrimers: From biomimicry to drug delivery and biomedical applications. Drug Discov Today 6:427-436. (Pubitemid 32328297)
25. Patri AK, Majoros IJ, Baker JR. 2002. Dendritic polymer macromolecular carriers for drug delivery. Curr Opin Chem Biol 6:466-471. (Pubitemid 34804769)
26. Lee CC, MacKay JA, Frechet JM, Szoka FC. 2005. Designing dendrimers for biological applications. Nat Biotechnol 23:1517-1526.
27. Svenson S, Tomalia DA. 2005. Dendrimers in biomedical applications-Reflections on the field. Adv Drug Deliv Rev 57:2106-2129.
28. Pardridge WM. 2003. Blood-brain barrier drug targeting: The future of brain drug development. Mol Intervent 3:90-105.
29. Smith MW, Gumbleton M. 2006. Endocytosis at the blood-brain barrier: From basic understanding to drug delivery strategies. J Drug Target 14:191-214. (Pubitemid 43922061)
30. Dhanikula RS, Hildgen P. 2006. Synthesis and evaluation of novel dendrimers with a hydrophilic interior as nanocarriers for drug delivery. Bioconjug Chem 17:29-41. (Pubitemid 43157582)
31. Gabizon AA, Barenholz Y, Bialer M. 1993. Prolongation of the circulation time of doxorubicin encapsulated in liposomes containing a polyethylene glycol-derivatized phospholipid: Pharmacokinetic studies in rodents and dogs. Pharm Res 10:703-708. (Pubitemid 23152316)
32. Klibanov AL, Maruyama K, Torchilin VP, Huang L. 1990. Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes. FEBS Lett 268:235-237. (Pubitemid 20233874)
33. Dhanikula RS, Hildgen P. 2007. Influence of molecular architecture of polyether-co-polyester dendrimers on the encapsulation and release of methotrexate. Biomaterials 28:3140-3152. (Pubitemid 46656188)
34. Rudt S, Muller RH. 1992. In vitro phagocytosis assay of nano- and microparticles by chemiluminescence. I. Effect of analytical parameters, particle size and particle concentration. J Control Release 22:263-272.
35. Rudt S, Muller RH. 1993. In vitro phagocytosis assay of nano- and microparticles by chemiluminescence. II. Effect of surface modification by coating of particles with poloxamer on the phagocytic uptake. J Control Release 25:51-59.
36. Omidi Y, Campbell L, Barar J, Connell D, Akhtar S, Gumbleton M. 2003. Evaluation of the immortalised mouse brain capillary endothelial cell line, b.End3, as an in vitro blood-brain barrier model for drug uptake and transport studies. Brain Res 990:95-112. (Pubitemid 37247600)
37. Augustijns P, Mols R. 2004. HPLC with programmed wavelength fluorescence detection for simultaneous determination of marker compounds of integrity and P-gp functionality in Caco-2 intestinal absorption model. J Pharm Biomed Anal 34:971-978. (Pubitemid 38296400)
38. Hilgendorf C, Spahn-Langguth H, Regardh CG, Lipka E, Amidon GL, Langguth P. 2000. Caco-2 versus Caco-2/HT29-MTX co-cultured cell lines: Permeabilities via diffusion, inside- and outside-directed carrier-mediated transport. J Pharm Sci 89:63-75. (Pubitemid 30080155)
39. Miret S, Abrahamse L, Groene EMd. 2004. Comparison of in vitro models for the prediction of compound absorption across the human intestinal mucosa. J Biomol Screen 9:598. (Pubitemid 40503517)
40. Fischer D, Li YX, Ahlemeyer B, Krieglstein J, Kissel T. 2003. In vitro cytotoxicity testing of polycations: Influence of polymer structure on cell viability and hemolysis. Biomaterials 24:1121-1131.
41. Malik N, Wiwattanapatapee R, Klopsch R, Lorenz K, Frey H, Weener JW, Meijer EW, Paulus W, Duncan R. 2000. Dendrimers: Relationship between structure and biocompatibility in vitro, and preliminary studies on the biodistribution of 125I-labelled polyamidoamine dendrimers in vivo. J Control Release 65:133-148. (Pubitemid 30122922)
42. Jevapresphant R, Penny J, Jalal R, Attwood D, Mckeown NB, D'Emanuele A. 2003. The influence of surface modification on cytotoxicity of PAMAM dendrimers. Int J Pharm 252:263-266. (Pubitemid 36126635)
43. Rupper A, Cardelli J. 2001. Regulation of phagocytosis and endosomal trafficking pathways in Dictyostelium discoideum. Biochim Biophys Acta 1525:205-216. (Pubitemid 32226417)
44. Silverstein SC, Steinman RM, Cohn ZA. 1977. Endocytosis. Ann Rev Biochem 46:669-722.
45. Axline SG, Reaven EP. 1974. Inhibition of phagocytosis and plasma membrane motility of the cultivated macrophage by cytochalasin B. J Cell Biol 62:647-659.
46. Catizone A, Albani ALM, Reola F, Alescio T. 1993. A quantitative assessment of non-specific pinocytosis by human endothelial cells surviving in vitro. Cell Mol Biol 39:155-169.
47. Heuser JE, Anderson RGW. 1989. Hypertonic media inhibits receptor mediated endocytosis by blocking clathrin-coated pit formation. J Cell Biol 108:389-400.
48. Davoust J, Gruenberg J, Howell KE. 1988. Two threshold values of low pH block endocytosis at different stages. Eur Mol Biol Organ J 6:3601-3609.
49. Sandvig SK, Olsnes S, Peterson OW, Deurs Bv. 1987. Acidification of the cytosol inhibits endocytosis from coated pits. J Cell Biol 105:679-689. (Pubitemid 18043831)
50. Larkin JM, Brown MS, Goldstein JL, Anderson RGW. 1983. Depletion of intracellular potassium arrests coated pit function and receptor mediated endocytosis in fibroblasts. Cell 33:273-285.
51. Larkin JM, Donzell WC, Goldstein JL, Anderson RGW. 1985. Modulation of intracellular potassium and ATP: Effects on coated pit function in fibroblasts and hepatocytes. J Cell Physiol 124:372-378.
52. Minana R, Duran JM, Tomas M, Renau-Piqueras J, Guerri C. 2001. Neural cell adhesion molecule is endocytosed via a clathrin-dependent pathway. Eur J Neurosci 13:749-756. (Pubitemid 32174799)
53. Wang LH, Rothberg KG, Anderson RG. 1993. Misassembly of clathrin lattices on endosomes reveals a regulatory switch for coated pit formation. J Cell Biol 123:1107-1117. (Pubitemid 23352421)
54. Furuchi T, Anderson GW. 1998. Cholestrol depletion of caveolae causes hyperactivation of extracellular signal-related kinase. J Biol Chem 273:21099-21104. (Pubitemid 28385396)
55. Song L, Pachter JS. 2003. Culture of murine brain microvascular endothelial cells that maintain expression and cytoskeletal association of tight junction-associated proteins. In Vitro Cell Dev Biol Anim 39:313-320. (Pubitemid 38200254)
56. Batrakova EV, Han HY, Miller DW, Kabanov AV. 1998. Effects of pluronic P85 unimers and micelles on drug permeability in polarized BBMEC and Caco-2 cells. Pharm Res 15:1525-1532.